Tobias Fleischmann

发表

Nonessential Plastid-Encoded Ribosomal Proteins in Tobacco: A Developmental Role for Plastid Translation and Implications for Reductive Genome Evolution[W][OA]

R. Bock, M. Schöttler, Lars B. Scharff, 2011, Plant Cell.

Evolutionary constraints on the plastid tRNA set decoding methionine and isoleucine

R. Bock, Lars B. Scharff, Sibah Alkatib, 2012, Nucleic acids research.

The Ribosome Biogenesis Protein Nol9 Is Essential for Definitive Hematopoiesis and Pancreas Morphogenesis in Zebrafish

Steven A. Harvey, D. Stemple, I. Barroso, 2015, PLoS genetics.

Clinical trials with investigational medicinal products consisting of or containing genetically modified organisms: implementation of Clinical Trials Regulation EU 536/2014

V. Acha, T. Ruppert, S. Beattie, 2021, Cell and Gene Therapy Insights.

Assessing the environmental fate of rAAV in activated sludge and water: Implications for environmental risk assessments and GMO regulatory frameworks.

Tobias Fleischmann, 2023, Journal of environmental management.

The Contributions of Wobbling and Superwobbling to the Reading of the Genetic Code

R. Bock, M. Rogalski, M. Schöttler, 2012, PLoS genetics.

Synthetic Lethality in the Tobacco Plastid Ribosome and Its Rescue at Elevated Growth Temperatures[W]

R. Bock, Lars B. Scharff, S. Ruf, 2014, Plant Cell.

Impact of genetically modified organism requirements on gene therapy development in the EU, Japan, and the US

K. Wonnacott, Seoan Huh, Tobias T. Fleischmann, 2022, Molecular therapy. Methods & clinical development.

Impact of genetically modiﬁed organism requirements on gene therapy development in the EU, Japan, and the US

K. Wonnacott, Seoan Huh, Tobias T. Fleischmann, 2022 .

Synthetic Lethality in the Tobacco Plastid Ribosome and Its Rescue at Elevated Growth Temperatures[W]

R. Bock, Lars B. Scharff, S. Ruf, 2014, Plant Cell.